Skip to main content
. 2014 Oct 2;5(10):e1443. doi: 10.1038/cddis.2014.395

Figure 1.

Figure 1

GBM cells with mesenchymal features have enhanced migratory capacity in vitro. (a) Phase contrast microscopic pictures ( × 10) of the newly generated GBM cell line GG7 along with the commercially available U87 and U251 cells. (b) Immunofluorescence analysis for mesenchymal (Fibronectin, COL5A1), proneural (PDGFR-α) and classic (EGFR) markers. (c) Wound healing assays comparing the migratory capacity of U87 versus GG7 cells at different time points. A representative experiment is shown. (d) Quantified data of wound healing assays where each data point represents the mean of at least three independent experiments±S.E.M. (***P<0.001 GG7 versus U87 for their respective time points)